ELI LILLY AND COMPAN

LLY
Delayed Quote. Delayed  - 07/01 04:03:17 pm
324.71USD +0.15%

Turn to zoom
Prev.324.7100
Open323.8800
High325.4000
Low317.7600
Volume1 817 810
Latest news
2d ago
4d ago
4d ago
4d ago
Chart ELI LILLY AND COMPANY
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance327327326
Spread/Res.-0,78%-0,78%-0,28%
Spread/Supp.6,1%13%16%
Support306286279
Financials
Sales 2022 29 054 M - -
Net income 2022 6 999 M - -
Net Debt 2022 9 508 M - -
P/E ratio 2022 42,8x
Yield 2022 1,17%
Capitalization 292 B 292 B -
EV / Sales 2022 10,4x
EV / Sales 2023 9,84x
Nbr of Employees 35 000
Free-Float 99,8%
Company
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (46.6%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (20.3%);
- immunology diseases (11.8%);
- neurology (6.7%):...
Sector :
Other Pharmaceuticals
Calendar :
2022-08-04 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 324,71 $
Average target price 316,41 $
Spread / Average Target -2,56%